SNPMiner Trials (Home Page)
Report for SNP rs2066842
Developed by Shray Alag, 2020.
SNP Clinical Trial Gene
There is one clinical trial.
Clinical Trials
1 Prevalence of Host and Viral Genotypes in Patients With Chronic Hepatitis B and Hepatitis C Infection in India
This study will define the substantial disease burden associated with viral hepatitis in India, and provide a foundation to understand the host and viral determinants of disease pathogenesis that may ultimately impact treatment decisions and outcome
NCT01772121 Hepatitis B Hepatitis C MeSH:Hepatitis A Hepatitis C Hepatitis B Hepatitis B, Chronic Hepatitis
HPO:Hepatitis
Characterize the SNPs present in innate immune factors TLR7 (rs3853839, rs179008); TLR9 (rs41308230, rs5743844 ); RIG-I (rs11795404, rs10813831) and NOD2 (rs2067085, rs2066842), in patients with chronic hepatitis C or chronic hepatitis B in the different geographic regions of India.
Primary Outcomes
Description: Characterize the variation in the IL28B rs12979860 SNP that exists among patients with chronic hepatitis C or chronic hepatitis B infection, in the different geographic regions of India
Measure: Variation in the IL28B rs12979860 SNP Time: One VisitSecondary Outcomes
Description: Assess the prevalence of HBV and HCV genotypes and subtypes in different geographic regions of India
Measure: Prevelance of HBV and HCV genotypes Time: One VisitDescription: Characterize the SNPs present in innate immune factors TLR7 (rs3853839, rs179008); TLR9 (rs41308230, rs5743844 ); RIG-I (rs11795404, rs10813831) and NOD2 (rs2067085, rs2066842), in patients with chronic hepatitis C or chronic hepatitis B in the different geographic regions of India
Measure: Characterize the SNPs present in innate immune factors toll-like receptor 7 (TLR7) Time: One Visit